nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—Lisinopril—dilated cardiomyopathy	0.461	0.532	CbGbCtD
Fidaxomicin—ABCB1—Spironolactone—dilated cardiomyopathy	0.406	0.468	CbGbCtD
Fidaxomicin—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0151	0.113	CcSEcCtD
Fidaxomicin—Metabolic acidosis—Furosemide—dilated cardiomyopathy	0.0128	0.0957	CcSEcCtD
Fidaxomicin—Drug eruption—Furosemide—dilated cardiomyopathy	0.00821	0.0615	CcSEcCtD
Fidaxomicin—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00319	0.0239	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00286	0.0214	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00286	0.0214	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00267	0.02	CcSEcCtD
Fidaxomicin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00244	0.0183	CcSEcCtD
Fidaxomicin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00234	0.0175	CcSEcCtD
Fidaxomicin—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00229	0.0172	CcSEcCtD
Fidaxomicin—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00222	0.0166	CcSEcCtD
Fidaxomicin—Malnutrition—Furosemide—dilated cardiomyopathy	0.00221	0.0165	CcSEcCtD
Fidaxomicin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00219	0.0164	CcSEcCtD
Fidaxomicin—Flatulence—Furosemide—dilated cardiomyopathy	0.00217	0.0163	CcSEcCtD
Fidaxomicin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00216	0.0162	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00214	0.0161	CcSEcCtD
Fidaxomicin—Vomiting—Spironolactone—dilated cardiomyopathy	0.0021	0.0158	CcSEcCtD
Fidaxomicin—Rash—Spironolactone—dilated cardiomyopathy	0.00209	0.0156	CcSEcCtD
Fidaxomicin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00209	0.0156	CcSEcCtD
Fidaxomicin—Headache—Spironolactone—dilated cardiomyopathy	0.00207	0.0155	CcSEcCtD
Fidaxomicin—Anaemia—Furosemide—dilated cardiomyopathy	0.00204	0.0153	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.002	0.015	CcSEcCtD
Fidaxomicin—Nausea—Spironolactone—dilated cardiomyopathy	0.00197	0.0147	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00187	0.014	CcSEcCtD
Fidaxomicin—Dry mouth—Furosemide—dilated cardiomyopathy	0.00184	0.0138	CcSEcCtD
Fidaxomicin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00177	0.0132	CcSEcCtD
Fidaxomicin—Skin disorder—Furosemide—dilated cardiomyopathy	0.00175	0.0131	CcSEcCtD
Fidaxomicin—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00166	0.0124	CcSEcCtD
Fidaxomicin—Flatulence—Lisinopril—dilated cardiomyopathy	0.00163	0.0122	CcSEcCtD
Fidaxomicin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00162	0.0121	CcSEcCtD
Fidaxomicin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00157	0.0117	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00155	0.0116	CcSEcCtD
Fidaxomicin—Constipation—Furosemide—dilated cardiomyopathy	0.00154	0.0115	CcSEcCtD
Fidaxomicin—Anaemia—Lisinopril—dilated cardiomyopathy	0.00153	0.0115	CcSEcCtD
Fidaxomicin—Angioedema—Lisinopril—dilated cardiomyopathy	0.00151	0.0113	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00147	0.011	CcSEcCtD
Fidaxomicin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00142	0.0107	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.0014	0.0105	CcSEcCtD
Fidaxomicin—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00138	0.0103	CcSEcCtD
Fidaxomicin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00133	0.00994	CcSEcCtD
Fidaxomicin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00131	0.00983	CcSEcCtD
Fidaxomicin—Pruritus—Furosemide—dilated cardiomyopathy	0.00127	0.00954	CcSEcCtD
Fidaxomicin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.0012	0.00902	CcSEcCtD
Fidaxomicin—Dizziness—Furosemide—dilated cardiomyopathy	0.00119	0.00892	CcSEcCtD
Fidaxomicin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00119	0.00891	CcSEcCtD
Fidaxomicin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00117	0.0088	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00117	0.00874	CcSEcCtD
Fidaxomicin—Constipation—Lisinopril—dilated cardiomyopathy	0.00116	0.00866	CcSEcCtD
Fidaxomicin—Vomiting—Furosemide—dilated cardiomyopathy	0.00115	0.00858	CcSEcCtD
Fidaxomicin—Rash—Furosemide—dilated cardiomyopathy	0.00114	0.00851	CcSEcCtD
Fidaxomicin—Dermatitis—Furosemide—dilated cardiomyopathy	0.00113	0.0085	CcSEcCtD
Fidaxomicin—Headache—Furosemide—dilated cardiomyopathy	0.00113	0.00845	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00111	0.00828	CcSEcCtD
Fidaxomicin—Nausea—Furosemide—dilated cardiomyopathy	0.00107	0.00801	CcSEcCtD
Fidaxomicin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00107	0.008	CcSEcCtD
Fidaxomicin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000996	0.00746	CcSEcCtD
Fidaxomicin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000956	0.00716	CcSEcCtD
Fidaxomicin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000894	0.00669	CcSEcCtD
Fidaxomicin—Vomiting—Lisinopril—dilated cardiomyopathy	0.000859	0.00644	CcSEcCtD
Fidaxomicin—Rash—Lisinopril—dilated cardiomyopathy	0.000852	0.00638	CcSEcCtD
Fidaxomicin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000851	0.00638	CcSEcCtD
Fidaxomicin—Headache—Lisinopril—dilated cardiomyopathy	0.000847	0.00634	CcSEcCtD
Fidaxomicin—Nausea—Lisinopril—dilated cardiomyopathy	0.000803	0.00601	CcSEcCtD
